Development of a Therapeutics Curriculum to Enhance Knowledge of Fourth-Year Medical Students About Clinical Uses and Adverse Effects of Drugs
Authors:
- 28 March 2009
- journal article
- research article
- Published by Taylor & Francis in Teaching and Learning in Medicine
- Vol. 21 (2) , 148-152
Abstract
Background: Enhanced clinical pharmacology and therapeutics education of medical students is important for improving effective and safe drug therapy. Increased education about pharmacovigilance is needed because serious drug-induced adverse effects are increasing. Fostering the needed scientific approach to prescribing requires knowledge of evidence-based drug therapy, based on understanding clinical trials. Therapeutic agents with novel mechanisms of action are increasingly available, and an unbiased understanding of the risks and benefits of novel agents is also important. These issues can be addressed in clinical pharmacology courses. However, many medical schools lack sufficient clinical pharmacologists to teach such courses. The Southern Illinois University Medical School faculty implemented an Advanced Therapeutics course to address these issues. Description: Development of this course involved defining appropriate content and organizing preclinical pharmacology and clinical faculty into teaching teams. The course was offered to 4th-year medical students and covered clinical trial information, and cutting-edge therapeutic developments. The “ABCs of Pharmacology” is a mental algorithm that was presented in the sophomore year and reintroduced in this course. This algorithm emphasizes pharmacovigilance, which stresses the balance between positive and negative effects of pharmacological agents. General principles of clinical pharmacology and therapeutics were covered by a clinical pharmacologist. Most sessions on specific disease treatment involved an integrated presentation by a preclinical pharmacologist and a clinician with expertise in that topic, often in the context of clinical cases. Other important topics were emphasized, which reinforce individualization of therapy, including pharmacogenomics that may determine idiosyncratic responses. Feedback during and following the course was obtained via questionnaires. Evaluation: This approach was well received by participating students and graduates. Most students rated this course as a valuable experience. Conclusion: This approach appears useful for educating medical students about therapeutics at medical schools that lack sufficient clinical pharmacology faculty to mount such a course.Keywords
This publication has 24 references indexed in Scilit:
- Clinical pharmacology: the science of therapeuticsClinical Pharmacology & Therapeutics, 2007
- The value and future of clinical pharmacologyClinical Pharmacology & Therapeutics, 2007
- The Quality of Pharmacologic Care for Adults in the United StatesMedical Care, 2006
- Adverse Drug Reactions and Avalanches: Life at the Edge of ChaosThe Journal of Clinical Pharmacology, 2005
- Pregraduate teaching clinical pharmacology in GermanyEuropean Journal of Clinical Pharmacology, 2004
- Teaching safe and effective prescribing in UK medical schools: a core curriculum for tomorrow's doctorsBritish Journal of Clinical Pharmacology, 2003
- Adverse Drug Events in Ambulatory CareNew England Journal of Medicine, 2003
- Towards a core curriculum in clinical pharmacology for undergraduate medical students in EuropeEuropean Journal of Clinical Pharmacology, 2002
- Teaching rational prescribing: a new clinical pharmacology curriculum for medical schoolsNaunyn-Schmiedeberg's Archives of Pharmacology, 2002
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998